from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2864c/-

LFCtreatmentdescriptionclass of inhibitor

-0.998

Amikacinug/mL Amikacintranslation

0.266

Cap5-10ug/mL Capreomycintranslation

0.092

Rox10-50 ug/mL Roxithromycintranslation

-0.386

SM2-5 ug/mL Streptomycintranslation

-1.402

Tet5-10 ug/mL Tetracyclinetranslation

0.262

Rif0.2-5ug/mL Rifampicintranscription

-0.163

Rifp0.1-0.5ug/mL Rifapentinetranscription

-3.642

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.091

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.314

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.144

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.064

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.133

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.880

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.413

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.061

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.855

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.247

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.139

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.089

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.101

KCN5-20 ug/mL Potassium cyaniderespiration

0.298

NaN30.2-2 mM Sodium aziderespiration

-0.414

Nigericin50 uM Nigericinrespiration

-0.259

TRC10-150 ug/mL Triclosanrespiration

-1.395

TRZ10-25 ug/mL Thioridazinerespiration

-0.810

Valinomycin0.5-10 uM Valinomycinrespiration

0.002

ZnSO42 mM ZnSO4respiration

-0.741

menadione6-10 ug/mL Menadionerespiration

-1.020

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.391

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.439

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.277

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.521

NRP_1Non-replicating persistence stage 1dosRassociated

0.730

Amp0.2mg/mL AmpicillincellWall

0.903

Cephalexin20-100 ug/mL CephalexincellWall

-0.047

Cerulenin0.32-5 ug/mL CerulenincellWall

0.742

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.233

EMB10-20 ug/mL EthambutolcellWall

-0.464

Eta12-40 ug/mL EthionamidecellWall

-0.546

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.921

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.344

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.492

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.172

BZA0.12 mg/mL BenzamidearomaticAmides

0.929

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.416

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.322

H2O24 mM hydrogen peroxideDNAdamaging

0.060

Levo10 ug/mL LevofloxacinDNAdamaging

0.188

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.977

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.550

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.713

UVUV-irradiationDNAdamaging

-1.054

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.576

Antimycin12.5-50 ug/mL Antimycin A?

0.308

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.348

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.112

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.726

PA8240.2-2 ug/mL PA-824?

1.349

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.832

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.357

Verapamil50 uM Verapamil?

0.344

mercaptoethanol2 mM 2-Mercaptoethanol?

0.677

methoxatin10-20 ug/mL Methoxatin?